{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:40:22Z","timestamp":1791578422876,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s40263-021-00791-3","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T04:05:54Z","timestamp":1612843554000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Pharmacotherapy to Manage Central Post-Stroke Pain"],"prefix":"10.1007","volume":"35","author":[{"given":"Hanwool Ryan","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6001-5851","authenticated-orcid":false,"given":"Michael M.","family":"Bottros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,7]]},"reference":[{"issue":"1","key":"791_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1155\/2008\/754260","volume":"13","author":"JL Henry","year":"2008","unstructured":"Henry JL, Lalloo C, Yashpal K. Central poststroke pain: an abstruse outcome. Pain Res Manag. 2008;13(1):41\u20139. https:\/\/doi.org\/10.1155\/2008\/754260.","journal-title":"Pain Res Manag."},{"issue":"7","key":"791_CR2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/j.pain.0000000000001213","volume":"159","author":"S Haroutounian","year":"2018","unstructured":"Haroutounian S, Ford AL, Frey K, Nikolajsen L, Finnerup NB, Neiner A, et al. How central is central poststroke pain? The role of afferent input in poststroke neuropathic pain: a prospective, open-label pilot study. Pain. 2018;159(7):1317\u201324. https:\/\/doi.org\/10.1097\/j.pain.0000000000001213.","journal-title":"Pain"},{"issue":"9","key":"791_CR3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(09)70176-0","volume":"8","author":"H Klit","year":"2009","unstructured":"Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009;8(9):857\u201368. https:\/\/doi.org\/10.1016\/S1474-4422(09)70176-0.","journal-title":"Lancet Neurol."},{"issue":"2","key":"791_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0304-3959(94)00144-4","volume":"61","author":"G Andersen","year":"1995","unstructured":"Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain. 1995;61(2):187\u201393. https:\/\/doi.org\/10.1016\/0304-3959(94)00144-4.","journal-title":"Pain"},{"issue":"1","key":"791_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0304-3959(89)90108-5","volume":"36","author":"G Leijon","year":"1989","unstructured":"Leijon G, Boivie J. Central post-stroke pain: a controlled trial of amitriptyline and carbamazepine. Pain. 1989;36(1):27\u201336. https:\/\/doi.org\/10.1016\/0304-3959(89)90108-5.","journal-title":"Pain"},{"key":"791_CR6","doi-asserted-by":"publisher","first-page":"9318597","DOI":"10.1155\/2017\/9318597","volume":"2017","author":"AH Bashir","year":"2017","unstructured":"Bashir AH, Abdullahi A, Abba MA, Mukhtar NB. Central poststroke pain: its profile among stroke survivors in Kano, Nigeria. Behav Neurol. 2017;2017:9318597. https:\/\/doi.org\/10.1155\/2017\/9318597.","journal-title":"Behav Neurol."},{"key":"791_CR7","doi-asserted-by":"publisher","first-page":"2709654","DOI":"10.1155\/2018\/2709654","volume":"2018","author":"M Habibi-Koolaee","year":"2018","unstructured":"Habibi-Koolaee M, Shahmoradi L, Niakan Kalhori SR, Ghannadan H, Younesi E. Prevalence of stroke risk factors and their distribution based on stroke subtypes in Gorgan: a retrospective hospital-based study-2015-2016. Neurol Res Int. 2018;2018:2709654. https:\/\/doi.org\/10.1155\/2018\/2709654.","journal-title":"Neurol Res Int."},{"key":"791_CR8","doi-asserted-by":"publisher","unstructured":"Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin. 2008;26(4):871\u201395, vii. https:\/\/doi.org\/10.1016\/j.ncl.2008.07.003.","DOI":"10.1016\/j.ncl.2008.07.003"},{"issue":"5","key":"791_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/STROKEAHA.111.671008","volume":"44","author":"MJ O'Donnell","year":"2013","unstructured":"O\u2019Donnell MJ, Diener HC, Sacco RL, Panju AA, Vinisko R, Yusuf S, et al. Chronic pain syndromes after ischemic stroke: PRoFESS trial. Stroke. 2013;44(5):1238\u201343. https:\/\/doi.org\/10.1161\/STROKEAHA.111.671008.","journal-title":"Stroke"},{"issue":"840","key":"791_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/pgmj.71.840.598","volume":"71","author":"D Bowsher","year":"1995","unstructured":"Bowsher D. The management of central post-stroke pain. Postgrad Med J. 1995;71(840):598\u2013604. https:\/\/doi.org\/10.1136\/pgmj.71.840.598.","journal-title":"Postgrad Med J."},{"issue":"9","key":"791_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.02999.x.","journal-title":"Eur J Neurol."},{"issue":"5","key":"791_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1017\/cjn.2018.55","volume":"45","author":"MD Staudt","year":"2018","unstructured":"Staudt MD, Clark AJ, Gordon AS, Lynch ME, Morley-Forster PK, Nathan H, et al. Long-term outcomes in the management of central neuropathic pain syndromes: a prospective observational cohort study. Can J Neurol Sci. 2018;45(5):545\u201352. https:\/\/doi.org\/10.1017\/cjn.2018.55.","journal-title":"Can J Neurol Sci."},{"issue":"5","key":"791_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.pmn.2015.03.002","volume":"16","author":"H Oh","year":"2015","unstructured":"Oh H, Seo W. A comprehensive review of central post-stroke pain. Pain Manag Nurs. 2015;16(5):804\u201318. https:\/\/doi.org\/10.1016\/j.pmn.2015.03.002.","journal-title":"Pain Manag Nurs."},{"issue":"9","key":"791_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s40263-014-0194-y","volume":"28","author":"JS Kim","year":"2014","unstructured":"Kim JS. Pharmacological management of central post-stroke pain: a practical guide. CNS Drugs. 2014;28(9):787\u201397. https:\/\/doi.org\/10.1007\/s40263-014-0194-y.","journal-title":"CNS Drugs"},{"issue":"10","key":"791_CR15","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/00207450290026139","volume":"112","author":"M Shimodozono","year":"2002","unstructured":"Shimodozono M, Kawahira K, Kamishita T, Ogata A, Tohgo S, Tanaka N. Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine. Int J Neurosci. 2002;112(10):1173\u201381. https:\/\/doi.org\/10.1080\/00207450290026139.","journal-title":"Int J Neurosci."},{"issue":"8","key":"791_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40266-016-0389-7","volume":"33","author":"G Pickering","year":"2016","unstructured":"Pickering G, Marcoux M, Chapiro S, David L, Rat P, Michel M, et al. An algorithm for neuropathic pain management in older people. Drugs Aging. 2016;33(8):575\u201383. https:\/\/doi.org\/10.1007\/s40266-016-0389-7.","journal-title":"Drugs Aging."},{"issue":"6","key":"791_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/JCP.0000000000000608","volume":"36","author":"HK Greenblatt","year":"2016","unstructured":"Greenblatt HK, Greenblatt DJ. Antidepressant-associated hyponatremia in the elderly. J Clin Psychopharmacol. 2016;36(6):545\u20139. https:\/\/doi.org\/10.1097\/JCP.0000000000000608.","journal-title":"J Clin Psychopharmacol."},{"issue":"1","key":"791_CR18","first-page":"79","volume":"22","author":"M Mihanovic","year":"2010","unstructured":"Mihanovic M, Restek-Petrovic B, Bodor D, Molnar S, Oreskovic A, Presecki P. Suicidality and side effects of antidepressants and antipsychotics. Psychiatr Danub. 2010;22(1):79\u201384.","journal-title":"Psychiatr Danub."},{"issue":"10","key":"791_CR19","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1212\/01.wnl.0000244422.45278.ff","volume":"67","author":"PJ Siddall","year":"2006","unstructured":"Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology. 2006;67(10):1792\u2013800. https:\/\/doi.org\/10.1212\/01.wnl.0000244422.45278.ff.","journal-title":"Neurology."},{"issue":"4","key":"791_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000007979","volume":"40","author":"N Attal","year":"1998","unstructured":"Attal N, Brasseur L, Parker F, Chauvin M, Bouhassira D. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. Eur Neurol. 1998;40(4):191\u2013200. https:\/\/doi.org\/10.1159\/000007979.","journal-title":"Eur Neurol."},{"key":"791_CR21","doi-asserted-by":"publisher","unstructured":"Serpell MG, Neuropathic pain study G. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002;99(3):557\u201366. https:\/\/doi.org\/10.1016\/s0304-3959(02)00255-5.","DOI":"10.1016\/s0304-3959(02)00255-5"},{"issue":"2","key":"791_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/026921630001400216","volume":"14","author":"N Holtom","year":"2000","unstructured":"Holtom N. Gabapentin for treatment of thalamic pain syndrome. Palliat Med. 2000;14(2):167. https:\/\/doi.org\/10.1177\/026921630001400216.","journal-title":"Palliat Med."},{"issue":"5","key":"791_CR23","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.pain.2010.12.023","volume":"152","author":"JS Kim","year":"2011","unstructured":"Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011;152(5):1018\u201323. https:\/\/doi.org\/10.1016\/j.pain.2010.12.023.","journal-title":"Pain"},{"issue":"9697","key":"791_CR24","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","volume":"374","author":"I Gilron","year":"2009","unstructured":"Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009;374(9697):1252\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(09)61081-3.","journal-title":"Lancet"},{"issue":"5","key":"791_CR25","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/j.pain.0000000000000143","volume":"156","author":"JV Holbech","year":"2015","unstructured":"Holbech JV, Bach FW, Finnerup NB, Brosen K, Jensen TS, Sindrup SH. Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial. Pain. 2015;156(5):958\u201366. https:\/\/doi.org\/10.1097\/j.pain.0000000000000143.","journal-title":"Pain"},{"issue":"12","key":"791_CR26","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.pain.2013.05.043","volume":"154","author":"S Tesfaye","year":"2013","unstructured":"Tesfaye S, Wilhelm S, Lledo A, Schacht A, Tolle T, Bouhassira D, et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The \u201cCOMBO-DN study\u201d: a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154(12):2616\u201325. https:\/\/doi.org\/10.1016\/j.pain.2013.05.043.","journal-title":"Pain"},{"issue":"2","key":"791_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1212\/wnl.56.2.184","volume":"56","author":"K Vestergaard","year":"2001","unstructured":"Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001;56(2):184\u201390. https:\/\/doi.org\/10.1212\/wnl.56.2.184.","journal-title":"Neurology."},{"issue":"6","key":"791_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1468-1331.1998.560625.x","volume":"5","author":"PB Carrieri","year":"1998","unstructured":"Carrieri PB, Provitera VV, Lavorgna L, Bruno R. Response of thalamic pain syndrome to lamotrigine. Eur J Neurol. 1998;5(6):625\u20136. https:\/\/doi.org\/10.1046\/j.1468-1331.1998.560625.x.","journal-title":"Eur J Neurol."},{"issue":"1","key":"791_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0304-3959(96)03168-5","volume":"68","author":"S Canavero","year":"1996","unstructured":"Canavero S, Bonicalzi V. Lamotrigine control of central pain. Pain. 1996;68(1):179\u201381. https:\/\/doi.org\/10.1016\/s0304-3959(96)03168-5.","journal-title":"Pain"},{"issue":"5","key":"791_CR30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1212\/wnl.58.5.831-a","volume":"58","author":"S Canavero","year":"2002","unstructured":"Canavero S, Bonicalzi V, Paolotti R. Lack of effect of topiramate for central pain. Neurology. 2002;58(5):831\u20132. https:\/\/doi.org\/10.1212\/wnl.58.5.831-a.","journal-title":"Neurology."},{"issue":"2","key":"791_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1468-1331.2012.03857.x","volume":"20","author":"GJ Jungehulsing","year":"2013","unstructured":"Jungehulsing GJ, Israel H, Safar N, Taskin B, Nolte CH, Brunecker P, et al. Levetiracetam in patients with central neuropathic post-stroke pain: a randomized, double-blind, placebo-controlled trial. Eur J Neurol. 2013;20(2):331\u20137. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03857.x.","journal-title":"Eur J Neurol."},{"issue":"4","key":"791_CR32","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1212\/wnl.58.4.554","volume":"58","author":"N Attal","year":"2002","unstructured":"Attal N, Guirimand F, Brasseur L, Gaude V, Chauvin M, Bouhassira D. Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology. 2002;58(4):554\u201363. https:\/\/doi.org\/10.1212\/wnl.58.4.554.","journal-title":"Neurology."},{"issue":"8","key":"791_CR33","first-page":"679","volume":"41","author":"T Tanei","year":"2013","unstructured":"Tanei T, Kajita Y, Noda H, Takebayashi S, Hirano M, Nakahara N, et al. Efficacy of tramadol\/acetaminophen medication for central post-stroke pain. No Shinkei Geka. 2013;41(8):679\u201385.","journal-title":"No Shinkei Geka."},{"issue":"3","key":"791_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/AJP.0b013e31818a744d","volume":"25","author":"C Norrbrink","year":"2009","unstructured":"Norrbrink C, Lundeberg T. Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial. Clin J Pain. 2009;25(3):177\u201384. https:\/\/doi.org\/10.1097\/AJP.0b013e31818a744d.","journal-title":"Clin J Pain."},{"issue":"2","key":"791_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162\u201373. https:\/\/doi.org\/10.1016\/S1474-4422(14)70251-0.","journal-title":"Lancet Neurol."},{"issue":"2","key":"791_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0304-3959(92)90052-d","volume":"48","author":"T Bainton","year":"1992","unstructured":"Bainton T, Fox M, Bowsher D, Wells C. A double-blind trial of naloxone in central post-stroke pain. Pain. 1992;48(2):159\u201362. https:\/\/doi.org\/10.1016\/0304-3959(92)90052-d.","journal-title":"Pain"},{"issue":"3","key":"791_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1212\/wnl.54.3.564","volume":"54","author":"N Attal","year":"2000","unstructured":"Attal N, Gaude V, Brasseur L, Dupuy M, Guirimand F, Parker F, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology. 2000;54(3):564\u201374. https:\/\/doi.org\/10.1212\/wnl.54.3.564.","journal-title":"Neurology."},{"issue":"3","key":"791_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/01.ajp.0000173020.10483.13","volume":"22","author":"A Frese","year":"2006","unstructured":"Frese A, Husstedt IW, Ringelstein EB, Evers S. Pharmacologic treatment of central post-stroke pain. Clin J Pain. 2006;22(3):252\u201360. https:\/\/doi.org\/10.1097\/01.ajp.0000173020.10483.13.","journal-title":"Clin J Pain."},{"issue":"2\u20134","key":"791_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/00207459008985960","volume":"55","author":"GI Awerbuch","year":"1990","unstructured":"Awerbuch GI, Sandyk R. Mexiletine for thalamic pain syndrome. Int J Neurosci. 1990;55(2\u20134):129\u201333. https:\/\/doi.org\/10.3109\/00207459008985960.","journal-title":"Int J Neurosci."},{"issue":"9","key":"791_CR40","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/bf00868808","volume":"242","author":"S Canavero","year":"1995","unstructured":"Canavero S, Bonicalzi V, Pagni CA, Castellano G, Merante R, Gentile S, et al. Propofol analgesia in central pain: preliminary clinical observations. J Neurol. 1995;242(9):561\u20137. https:\/\/doi.org\/10.1007\/bf00868808.","journal-title":"J Neurol."},{"issue":"4","key":"791_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/01.wnf.0000138635.42121.9e","volume":"27","author":"S Canavero","year":"2004","unstructured":"Canavero S, Bonicalzi V. Intravenous subhypnotic propofol in central pain: a double-blind, placebo-controlled, crossover study. Clin Neuropharmacol. 2004;27(4):182\u20136. https:\/\/doi.org\/10.1097\/01.wnf.0000138635.42121.9e.","journal-title":"Clin Neuropharmacol."},{"issue":"1\u20132","key":"791_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/s0304-3959(00)00488-7","volume":"92","author":"PG Vick","year":"2001","unstructured":"Vick PG, Lamer TJ. Treatment of central post-stroke pain with oral ketamine. Pain. 2001;92(1\u20132):311\u20133. https:\/\/doi.org\/10.1016\/s0304-3959(00)00488-7.","journal-title":"Pain"},{"issue":"1\u20132","key":"791_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0304-3959(97)00028-6","volume":"72","author":"T Yamamoto","year":"1997","unstructured":"Yamamoto T, Katayama Y, Hirayama T, Tsubokawa T. Pharmacological classification of central post-stroke pain: comparison with the results of chronic motor cortex stimulation therapy. Pain. 1997;72(1\u20132):5\u201312. https:\/\/doi.org\/10.1016\/s0304-3959(97)00028-6.","journal-title":"Pain"},{"key":"791_CR44","unstructured":"Rosenbaum SB, Gupta V, Palacios JL. Ketamine. Treasure Island (FL): StatPearls; 2020."},{"key":"791_CR45","volume-title":"Lidocaine toxicity","author":"KD Torp","year":"2020","unstructured":"Torp KD, Simon LV. Lidocaine toxicity. Treasure Island (FL): StatPearls; 2020."},{"key":"791_CR46","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/JPR.S46530","volume":"6","author":"AJ Pellicane","year":"2013","unstructured":"Pellicane AJ, Millis SR. Efficacy of methylprednisolone versus other pharmacologic interventions for the treatment of central post-stroke pain: a retrospective analysis. J Pain Res. 2013;6:557\u201363. https:\/\/doi.org\/10.2147\/JPR.S46530.","journal-title":"J Pain Res."},{"key":"791_CR47","doi-asserted-by":"publisher","unstructured":"Anttila JE, Albert K, Wires ES, Matlik K, Loram LC, Watkins LR, et al. Post-stroke intranasal (+)-naloxone delivery reduces microglial activation and improves behavioral recovery from ischemic injury. eNeuro. 2018. https:\/\/doi.org\/10.1523\/ENEURO.0395-17.2018.","DOI":"10.1523\/ENEURO.0395-17.2018"},{"issue":"4","key":"791_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","volume":"33","author":"J Younger","year":"2014","unstructured":"Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451\u20139. https:\/\/doi.org\/10.1007\/s10067-014-2517-2.","journal-title":"Clin Rheumatol."},{"issue":"33","key":"791_CR49","doi-asserted-by":"publisher","first-page":"e11861","DOI":"10.1097\/MD.0000000000011861","volume":"97","author":"SJ Li","year":"2018","unstructured":"Li SJ, Zhang YF, Ma SH, Yi Y, Yu HY, Pei L, et al. The role of NLRP3 inflammasome in stroke and central poststroke pain. Medicine (Baltimore). 2018;97(33):e11861. https:\/\/doi.org\/10.1097\/MD.0000000000011861.","journal-title":"Medicine (Baltimore)."},{"issue":"8","key":"791_CR50","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389. https:\/\/doi.org\/10.1038\/s41577-019-0165-0.","journal-title":"Nat Rev Immunol."},{"issue":"2","key":"791_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10(2):128. https:\/\/doi.org\/10.1038\/s41419-019-1413-8.","journal-title":"Cell Death Dis."},{"issue":"1","key":"791_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/fcp.12316","volume":"32","author":"G Pickering","year":"2018","unstructured":"Pickering G, Morel V. Memantine for the treatment of general neuropathic pain: a narrative review. Fundam Clin Pharmacol. 2018;32(1):4\u201313. https:\/\/doi.org\/10.1111\/fcp.12316.","journal-title":"Fundam Clin Pharmacol."},{"issue":"7","key":"791_CR53","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/ejp.1393","volume":"23","author":"R Kurian","year":"2019","unstructured":"Kurian R, Raza K, Shanthanna H. A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. Eur J Pain. 2019;23(7):1234\u201350. https:\/\/doi.org\/10.1002\/ejp.1393.","journal-title":"Eur J Pain."},{"key":"791_CR54","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.2147\/DDDT.S207350","volume":"13","author":"E Martin","year":"2019","unstructured":"Martin E, Sorel M, Morel V, Marcaillou F, Picard P, Delage N, et al. Dextromethorphan and memantine after ketamine analgesia: a randomized control trial. Drug Des Devel Ther. 2019;13:2677\u201388. https:\/\/doi.org\/10.2147\/DDDT.S207350.","journal-title":"Drug Des Devel Ther."},{"issue":"4","key":"791_CR55","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1213\/ane.0b013e318180ebfe","volume":"107","author":"A Buvanendran","year":"2008","unstructured":"Buvanendran A, Kroin JS. Early use of memantine for neuropathic pain. Anesth Analg. 2008;107(4):1093\u20134. https:\/\/doi.org\/10.1213\/ane.0b013e318180ebfe.","journal-title":"Anesth Analg."},{"issue":"12","key":"791_CR56","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1016\/j.pain.2014.09.004","volume":"155","author":"B Olivan-Blazquez","year":"2014","unstructured":"Olivan-Blazquez B, Herrera-Mercadal P, Puebla-Guedea M, Perez-Yus MC, Andres E, Fayed N, et al. Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up. Pain. 2014;155(12):2517\u201325. https:\/\/doi.org\/10.1016\/j.pain.2014.09.004.","journal-title":"Pain"},{"issue":"1","key":"791_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90056-6","volume":"59","author":"HJ McQuay","year":"1994","unstructured":"McQuay HJ, Carroll D, Jadad AR, Glynn CJ, Jack T, Moore RA, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design. Pain. 1994;59(1):127\u201333. https:\/\/doi.org\/10.1016\/0304-3959(94)90056-6.","journal-title":"Pain"},{"issue":"11","key":"791_CR58","first-page":"844","volume":"63","author":"A Mu","year":"2017","unstructured":"Mu A, Weinberg E, Moulin DE, Clarke H. Pharmacologic management of chronic neuropathic pain: review of the Canadian Pain Society consensus statement. Can Fam Phys. 2017;63(11):844\u201352.","journal-title":"Can Fam Phys"},{"issue":"1","key":"791_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11916-018-0658-8","volume":"22","author":"G Lee","year":"2018","unstructured":"Lee G, Grovey B, Furnish T, Wallace M. Medical cannabis for neuropathic pain. Curr Pain Headache Rep. 2018;22(1):8. https:\/\/doi.org\/10.1007\/s11916-018-0658-8.","journal-title":"Curr Pain Headache Rep."},{"key":"791_CR60","doi-asserted-by":"publisher","unstructured":"Mucke M, Phillips T, Radbruch L, Petzke F, Hauser W. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;3(3):CD012182. https:\/\/doi.org\/10.1002\/14651858.CD012182.pub2.","DOI":"10.1002\/14651858.CD012182.pub2"},{"issue":"5\u20136","key":"791_CR61","doi-asserted-by":"publisher","first-page":"279","DOI":"10.19191\/EP17.5-6.AD01.069","volume":"41","author":"L Amato","year":"2017","unstructured":"Amato L, Minozzi S, Mitrova Z, Parmelli E, Saulle R, Cruciani F, et al. Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy. Epidemiol Prev. 2017;41(5\u20136):279\u201393. https:\/\/doi.org\/10.19191\/EP17.5-6.AD01.069.","journal-title":"Epidemiol Prev."},{"key":"791_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40945-018-0047-y","volume":"8","author":"D Corbetta","year":"2018","unstructured":"Corbetta D, Sarasso E, Agosta F, Filippi M, Gatti R. Mirror therapy for an adult with central post-stroke pain: a case report. Arch Physiother. 2018;8:4. https:\/\/doi.org\/10.1186\/s40945-018-0047-y.","journal-title":"Arch Physiother."},{"key":"791_CR63","doi-asserted-by":"publisher","unstructured":"Sachs AJ, Babu H, Su YF, Miller KJ, Henderson JM. Lack of efficacy of motor cortex stimulation for the treatment of neuropathic pain in 14 patients. Neuromodulation. 2014;17(4):303\u201310. https:\/\/doi.org\/10.1111\/ner.12181 (discussion 310\u20131).","DOI":"10.1111\/ner.12181"},{"issue":"6","key":"791_CR64","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/jnnp.2004.055806","volume":"76","author":"EM Khedr","year":"2005","unstructured":"Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry. 2005;76(6):833\u20138. https:\/\/doi.org\/10.1136\/jnnp.2004.055806.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"791_CR65","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.2147\/JPR.S216081","volume":"12","author":"BC Ramger","year":"2019","unstructured":"Ramger BC, Bader KA, Davies SP, Stewart DA, Ledbetter LS, Simon CB, et al. Effects of non-invasive brain stimulation on clinical pain intensity and experimental pain sensitivity among individuals with central post-stroke pain: a systematic review. J Pain Res. 2019;12:3319\u201329. https:\/\/doi.org\/10.2147\/JPR.S216081.","journal-title":"J Pain Res."},{"issue":"12","key":"791_CR66","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jpain.2009.03.010","volume":"10","author":"A Leung","year":"2009","unstructured":"Leung A, Donohue M, Xu R, Lee R, Lefaucheur JP, Khedr EM, et al. rTMS for suppressing neuropathic pain: a meta-analysis. J Pain. 2009;10(12):1205\u201316. https:\/\/doi.org\/10.1016\/j.jpain.2009.03.010.","journal-title":"J Pain."},{"issue":"11","key":"791_CR67","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1136\/jnnp.2008.146738","volume":"79","author":"PD McGeoch","year":"2008","unstructured":"McGeoch PD, Williams LE, Lee RR, Ramachandran VS. Behavioural evidence for vestibular stimulation as a treatment for central post-stroke pain. J Neurol Neurosurg Psychiatry. 2008;79(11):1298\u2013301. https:\/\/doi.org\/10.1136\/jnnp.2008.146738.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"5","key":"791_CR68","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/ana.24927","volume":"81","author":"SF Lempka","year":"2017","unstructured":"Lempka SF, Malone DA Jr, Hu B, Baker KB, Wyant A, Ozinga JGT, et al. Randomized clinical trial of deep brain stimulation for poststroke pain. Ann Neurol. 2017;81(5):653\u201363. https:\/\/doi.org\/10.1002\/ana.24927.","journal-title":"Ann Neurol."},{"key":"791_CR69","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.wneu.2017.06.173","volume":"106","author":"SGJ Boccard","year":"2017","unstructured":"Boccard SGJ, Prangnell SJ, Pycroft L, Cheeran B, Moir L, Pereira EAC, et al. Long-term results of deep brain stimulation of the anterior cingulate cortex for neuropathic pain. World Neurosurg. 2017;106:625\u201337. https:\/\/doi.org\/10.1016\/j.wneu.2017.06.173.","journal-title":"World Neurosurg."},{"issue":"2","key":"791_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/neuros\/nyy552","volume":"86","author":"LA Frizon","year":"2020","unstructured":"Frizon LA, Yamamoto EA, Nagel SJ, Simonson MT, Hogue O, Machado AG. Deep brain stimulation for pain in the modern era: a systematic review. Neurosurgery. 2020;86(2):191\u2013202. https:\/\/doi.org\/10.1093\/neuros\/nyy552.","journal-title":"Neurosurgery."},{"issue":"1\u20133","key":"791_CR71","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.pain.2009.09.011","volume":"147","author":"AE Pickering","year":"2009","unstructured":"Pickering AE, Thornton SR, Love-Jones SJ, Steeds C, Patel NK. Analgesia in conjunction with normalisation of thermal sensation following deep brain stimulation for central post-stroke pain. Pain. 2009;147(1\u20133):299\u2013304. https:\/\/doi.org\/10.1016\/j.pain.2009.09.011.","journal-title":"Pain"},{"issue":"6","key":"791_CR72","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2176\/nmc.oa.2018-0292","volume":"59","author":"T Tanei","year":"2019","unstructured":"Tanei T, Kajita Y, Takebayashi S, Aoki K, Nakahara N, Wakabayashi T. Predictive factors associated with pain relief of spinal cord stimulation for central post-stroke pain. Neurol Med Chir (Tokyo). 2019;59(6):213\u201321. https:\/\/doi.org\/10.2176\/nmc.oa.2018-0292.","journal-title":"Neurol Med Chir (Tokyo)."},{"issue":"Pt 2","key":"791_CR73","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-3-211-33081-4_13","volume":"97","author":"SL Owen","year":"2007","unstructured":"Owen SL, Green AL, Nandi DD, Bittar RG, Wang S, Aziz TZ. Deep brain stimulation for neuropathic pain. Acta Neurochir Suppl. 2007;97(Pt 2):111\u20136. https:\/\/doi.org\/10.1007\/978-3-211-33081-4_13.","journal-title":"Acta Neurochir Suppl."},{"issue":"12","key":"791_CR74","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1161\/01.str.0000037674.95228.86","volume":"33","author":"C Lampl","year":"2002","unstructured":"Lampl C, Yazdi K, Roper C. Amitriptyline in the prophylaxis of central poststroke pain: preliminary results of 39 patients in a placebo-controlled, long-term study. Stroke. 2002;33(12):3030\u20132. https:\/\/doi.org\/10.1161\/01.str.0000037674.95228.86.","journal-title":"Stroke"},{"issue":"10","key":"791_CR75","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1161\/STROKEAHA.115.010259","volume":"46","author":"SM Mulla","year":"2015","unstructured":"Mulla SM, Wang L, Khokhar R, Izhar Z, Agarwal A, Couban R, et al. Management of central poststroke pain: systematic review of randomized controlled trials. Stroke. 2015;46(10):2853\u201360. https:\/\/doi.org\/10.1161\/STROKEAHA.115.010259.","journal-title":"Stroke"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-021-00791-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-021-00791-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-021-00791-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T15:38:34Z","timestamp":1614267514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-021-00791-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1007\/s40263-021-00791-3","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"7 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Hanwool Ryan Choi, Adem Aktas, and Michael Bottros have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}